Likewise, depletion of the cell cycle-related kinase (CCRK) reduced tumor-infiltrating MDSCs and increased intratumor CD8+ T cells, thus enhancing the efficacy of PD-L1 inhibitor to eradicate HCC (217). This evidence concerns the gene CDK20 and hepatocellular carcinoma.